Brazil has enormous potential in global clinical development. But how can that potential be translated into faster activation, stronger patient recruitment, and clinical trials that actually deliver?
ODC Life Sciences is inviting leaders from across biotechnology, pharmaceuticals, clinical research, healthcare, regulation, and investment to Clinical Development in LATAM: Brazil Unlocked, taking place on September 24, 2026, at the MassBio Hub, Kendall Square in Cambridge, Massachusetts.
The gathering will bring together professionals working across the clinical development ecosystem to explore what it really takes to conduct successful studies in Brazil and Latin America, moving beyond the region’s potential to focus on execution.
Why Brazil and Why Now?
Latin America is becoming increasingly important to global drug development, and Brazil sits at the center of that opportunity.
A large and diverse patient population, established research centers, experienced investigators, developing genomic infrastructure, and growing participation in international studies all contribute to Brazil’s potential as a clinical research destination.
But opportunity alone does not make a clinical trial successful.
Regulatory pathways, ethics approvals, site activation, patient identification, recruitment, local relationships, and coordination between stakeholders can ultimately determine whether a study delivers.
That is where Brazil Unlocked will focus: bringing global expectations together with the local expertise required to turn clinical development plans into results.
Bringing the Clinical Development Ecosystem Together
The event will bring perspectives from biotechnology leadership, government and regulatory affairs, medical societies, clinical trial operations, technology, investment, and organizations working directly within Brazil’s research ecosystem.
Confirmed speakers include Cedric Francois, Founder and Former CEO of Apellis Pharmaceuticals; Jennifer S. Buell, CEO of Agenus and MiNK Therapeutics; Renato Alencar Porto, President of Interfarma and former ANVISA Director; Maiko Tonini, Coordinator at the Brazilian Ministry of Health’s INAEP Ethical Chamber; Matthew H. Maxwell, clinical trial technology and execution expert; and industry investor Edward Chan.
The program will also feature Fábio Franke, President-Elect of the Sociedade Brasileira de Oncologia Clínica (SBOC); Jorge Rocha, President of the Brazilian Retina Society (SBRV); José Moura-Neto, President of the Brazilian Society of Nephrology (SBN); Tarek Ebrahim, Senior Medical Strategy and Medical Affairs Leader; and Angelo Orru Neto, CEO of iHealth.
Representing ODC Life Sciences will be Daniel Zequeto, Founder and CEO; Tatiana Cacioli, Head of Operations and Regulatory Affairs; Marcie Goodale, Global Head of Business Development; and Arthur Furlan, Head of Strategic Partnerships.
From Potential to Performance
The goal of the meeting is not simply to discuss why Brazil is attractive for clinical research. It is to examine what sponsors, research sites, physicians, CROs, technology partners, and local organizations need to do together to make clinical development work in practice.
How can sponsors navigate Brazil more effectively? What determines successful patient recruitment? Where do regulatory and operational bottlenecks emerge? And how can local knowledge help global development programs move faster while maintaining scientific and operational standards?
These are the conversations ODC Life Sciences hopes to bring into one room in Cambridge.
Join the Event at MassBio Hub
Clinical Development in LATAM: Brazil Unlocked will take place:
Date: September 24, 2026
Time: 3:30 PM EDT
Venue: MassBio Hub – Kendall Square
Address: 700 Technology Square, 5th Floor, Cambridge, Massachusetts 02139, USA
ODC Life Sciences invites professionals involved in clinical development, biotechnology, pharmaceuticals, clinical operations, research sites, patient recruitment, regulatory affairs, medical affairs, and investment to join the discussion.
If Brazil and Latin America are part of your clinical development strategy, or you are considering whether they should be, this is an opportunity to meet the people working across the ecosystem and understand what successful execution in the region requires.
For more oncology events, conferences, and global health meetings, follow OncoCalendar by OncoDaily and stay up to date with what’s happening worldwide.